A phase II study of trifluridine/tipiracil, irinotecan, and bevacizumab in pretreated metastatic colorectal cancer (TABAsCO). Background: Immune checkpoint inhibitors ...

A multicenter, single-arm, phase II study of nivolumab in patients with biliary tract cancer with a PD-L1 combined positive score ≥ 1. Achievement of cancer- and treatment-free status by atezolizumab ...

Hackensack Meridian Health Bayshore Medical Center now offers Y-90 radioembolization, an advanced and minimally invasive method to treat liver tumors without surgery. This procedure is used to treat ...

ABK Biomedical, Inc. announced the first patient treated in ABK’s First-in-Human study with Eye90 microspheres™, a Y90 radioembolization device for the treatment of liver cancers. This study is being ...

Children’s Healthcare of Atlanta is one of the first pediatric centers to offer Y90 Radioembolization treatment to pediatric patients with liver cancer. The system recently completed treatment on its ...

Hackensack Meridian Health Riverview Medical Center is pleased to announce that it now offers Y-90 radioembolization, an innovative and minimally invasive method to treat liver tumors without surgery.

HALIFAX, NS, Feb. 24, 2026 /CNW/ - ABK Biomedical, Inc., an innovative, medical device company dedicated to the research, development, and commercialization of advanced imageable embolic medical ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. He's also one of ...

None — Liver Cancer Cancer is classified as being primary (the site of origin) or metastatic (spread from another area of the body). The American Cancer Society estimates that 24,120 new cases of ...